FCAP
First Capital, Inc.
FCAP trails on the overall score without a compensating advantage in the available component scores.
MS
Morgan Stanley
MS has the edge over FCAP overall, supported by stronger modeled upside and lower modeled downside.
FCAP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
FCAP's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FCAP.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
FCAP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.7x | $43.83 | -34% |
| Fair | 11x | $62.24 | -5.7% |
| Current | 12x | $66.00 | — |
| Expensive | 17x | $97.27 | +47% |
Historical ranges are pointers, not guarantees.
FCAP has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
FCAP Forward outlook
There aren't enough analyst estimates for FCAP to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
FCAP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $5.72 | +30% |
| Q2 2026 | $5.53 | +40% |
| Q1 2026 | $5.23 | +43% |
| Q4 2025 | $4.90 | +37% |
| Q3 2025 | $4.41 | +25% |
| Q2 2025 | $3.94 | +9.4% |
| Q1 2025 | $3.66 | +2.5% |
| Q4 2024 | $3.57 | -6.8% |
FCAP earned $5.72 per share over the past year, up 30% from the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over FCAP on earnings, with more consistent year-over-year improvement.
FCAP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.8M | +12% |
| Q2 2026 | $14.3M | +15% |
| Q1 2026 | $13.5M | +18% |
| Q4 2025 | $13.5M | +19% |
| Q3 2025 | $13.3M | +21% |
| Q2 2025 | $12.4M | +16% |
| Q1 2025 | $11.4M | +8.9% |
| Q4 2024 | $11.3M | +9.3% |
FCAP's revenue has grown year over year for 10 quarters in a row: $15M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 43% | +1 points |
| Q2 2026 | 42% | +4.8 points |
| Q1 2026 | 40% | +5.6 points |
| Q3 2025 | 42% | +10 points |
| Q2 2025 | 37% | +6.2 points |
| Q1 2025 | 34% | +1.2 points |
| Q4 2024 | 35% | +0.2 points |
| Q3 2024 | 31% | -4 points |
FCAP has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over FCAP on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
FCAP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.8M | -13% |
| Q2 2026 | $3.5M | +2.7% |
| Q1 2026 | $5.9M | +40% |
| Q4 2025 | $4.5M | +21% |
| Q3 2025 | $7.8M | +3.7% |
| Q2 2025 | $3.5M | +3.8% |
| Q1 2025 | $4.2M | -41% |
| Q4 2024 | $3.7M | +385% |
FCAP has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
FCAP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +748 shares |
| 1 year | -0.2% | -5.7K shares |
| 3 years | -0.4% | -14.6K shares |
| 5 years | -0.3% | -8.8K shares |
| Available history | -0.1% | -3.6K shares |
FCAP has 3M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $517,000 |
| Q3 2025 | $52,000 |
| Q2 2025 | — |
| Q1 2025 | $9,000 |
| Q4 2024 | — |
| Q3 2024 | $28,000 |
| Q2 2024 | $13,000 |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over FCAP on shareholder dilution, with a more favorable share count trend.
FCAP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -1.1x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.7x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
| Q3 2024 | -1.4x | Net Cash |
| Q2 2024 | -1.5x | Net Cash |
| Q1 2024 | -1.3x | Net Cash |
| Q4 2023 | -1.2x | Net Cash |
FCAP has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FCAP.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
FCAP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.3 | Neutral |
| Stochastic | 64.3 | Neutral |
FCAP's weekly RSI is 60 (neutral) and its Stochastic is 64 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
FCAP PE vs Financial Services Sector
| Metric | FCAP | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 11% below |
| PE % | 58 | 63 | 5 pts below |
FCAP has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
FCAP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.7 | 5.3% above |
| 20 week MA | $62.8 | 5.1% above |
| 50 week MA | $58.6 | 13% above |
| 100 week MA | $49.6 | 33% above |
| 200 week MA | $39.5 | 67% above |
FCAP has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
FCAP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $68.5 | $63.1 | -7.9% |
| 2021 | $63.1 | $40.5 | -36% |
| 2022 | $40.5 | $24.4 | -40% |
| 2023 | $24.4 | $27.9 | +14% |
| 2024 | $27.9 | $32.3 | +16% |
| 2025 | $32.3 | $59.9 | +86% |
| 2026 YTD | $59.9 | $66.0 | +10% |
FCAP has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.